The U.S. Food and Drug Administration has approved Xenpozyme (olipudase alfa) for pediatric and adult patients with acid sphingomyelinase deficiency (ASMD), a rare genetic disease.
Premature ovarian aging (POA) refers to an early decline in ovarian function; it is the main cause of infertility in older women and is characterized by […]